Moore Capital Management, LP Syndax Pharmaceuticals Inc Transaction History
Moore Capital Management, LP
- $7.76 Billion
- Q4 2024
A detailed history of Moore Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Moore Capital Management, LP holds 50,000 shares of SNDX stock, worth $746,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$746,000% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SNDX
# of Institutions
227Shares Held
95.1MCall Options Held
759KPut Options Held
635K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$127 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$118 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$88.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$79.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$72.8 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $844M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...